Data / Form D filings / NKore Biotherapeutics, LLC
NKore Biotherapeutics, LLC: Form D filing
NKore Biotherapeutics, LLC, a biotechnology company in Germantown, TN, filed a Form D with the SEC in 2023. The latest, on April 13, 2023, reports $250,000 sold of a $3 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2309 DUNTREATH RD, Germantown, TN, 38139
- Phone
- (615) 618-9548
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1973285
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 13, 2023 | New notice | $3,000,000 | $250,000 | $2,750,000 | 2 | Mar 24, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| R Gregory Brophy | Executive Officer, Director | |
| Tracy Ryan | Executive Officer, Director | |
| Timothy Brahm | Director | |
| Diederik van der Reijt | Director |
Other biotechnology companies in Tennessee that filed recently
- Synomis, Inc. $30,000 · Oct 30, 2026
- TM Holding Companies, Inc. $3.7 million · Oct 8, 2026
Every Form D from the week of Apr 10, 2023 · All recent filings in Tennessee · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NKore Biotherapeutics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.